Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. (Q54625083)

1 June 2018

title

Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. (English)

1 reference

1 June 2018

0 references

2

1 reference

1 June 2018

Norbert Weissmann

7

1 reference

1 June 2018

Ralph T Schermuly

9

1 reference

1 June 2018

author name string

Henrik ten Freyhaus

1

1 reference

1 June 2018

Maike Leuchs

3

1 reference

1 June 2018

Marius Vantler

4

1 reference

1 June 2018

Eva M Berghausen

5

1 reference

1 June 2018

Evren Caglayan

6

1 reference

1 June 2018

Bhola K Dahal

8

1 reference

1 June 2018

Arne Ostman

10

1 reference

1 June 2018

Kai Kappert

11

1 reference

1 June 2018

Stephan Rosenkranz

12

1 reference

1 June 2018

language of work or name

English

0 references

publication date

22 December 2010

1 reference

1 June 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

1 June 2018

volume

183

1 reference

1 June 2018

issue

8

1 reference

1 June 2018

page(s)

1092-1102

1 reference

1 June 2018

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47phox is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Tyrosine phosphatases in vessel wall signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Regulation of platelet-derived growth factor receptor activation by afadin through SHP-2: implications for cellular morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Role of epidermal growth factor inhibition in experimental pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Alterations in Ca2+ cycling by lysoplasmenylcholine in adult rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

The effects of hypoxia on the cells of the pulmonary vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Heterotrimeric G proteins and the platelet-derived growth factor receptor-beta contribute to hypoxic proliferation of smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Protein-tyrosine phosphatases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

A brake becomes an accelerator: PTP1B--a new therapeutic target for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Modulation of vascular gene expression by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1663OC

10.1164/RCCM.200911-1663OC

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018